# The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer

> **NCT03117023** · PHASE3 · UNKNOWN · sponsor: **Nanjing PLA General Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** dexmedetomidine

## Key facts

- **NCT ID:** NCT03117023
- **Lead sponsor:** Nanjing PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-15
- **Primary completion:** 2017-05-15
- **Final completion:** 2017-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117023, "The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03117023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*